A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer’s disease - Feldman, H; Gauthier, S; Hecker, J; Vellas, B; Subbiah, P; Whalen, E; and the Donepezil MSAD Study Investigators Group (Neurology, 2001)